Syneos Health, Inc. (NASDAQ:SYNH)

About the company

Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC.

Sector

Health Services

Industry

Services to the Health Industry

Employees

24000

$5B

Total Revenue

24K

Employees

$6B

Market Capitalization

30.93

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$1038M

Operating Margin (in %)

Total operating margin

$349M

Net Margin (in %)

Total net margin

$195M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
IQVIA Holdings, Inc. IQV 28020.96 11158.00 4.88 129.83 1.93
Laboratory Corp. of America Holdings LH 16368.94 11587.00 2.31 51.87 2.77
Quest Diagnostics, Inc. DGX 15781.44 7726.00 2.74 18.48 10.33
Syneos Health, Inc. SYNH 6098.18 4720.00 2.01 30.93 4.13
National Research Corp. NRC 1517.10 130.00 39.43 41.68 27.51
Apollo Medical Holdings, Inc. AMEH 591.12 625.00 2.96 32.84 2.89
Bioanalytical Systems, Inc. BASI 57.64 55.00 5.76 -24.95 -3.94
Protalix Biotherapeutics, Inc. PLX 55.95 66.00 -3.93 -5.92 -14.18
Psychemedics Corp. PMD 34.74 35.00 2.02 41.36 2.14
Interpace Biosciences, Inc. IDXG 24.56 24.00 1.91 -0.85 -112.78
Pressure BioSciences, Inc. PBIO 4.50 2.00 -0.52 -0.28 -876.69

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Public Employees Retirement Association of Colorado Increases Stock Position in Syneos Health Inc (NASDAQ:SYNH)

12h ago, source: theenterpriseleader.com

Public Employees Retirement Association of Colorado lifted its stake in Syneos Health Inc (NASDAQ:SYNH) by 47.8% in the 1st ...

Hedge Funds Are Nibbling On Syneos Health, Inc. (SYNH)

16d ago, source: YAHOO!

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will ...

Q3 2020 EPS Estimates for Syneos Health Inc (NASDAQ:SYNH) Reduced by Jefferies Financial Group

10d ago, source: modernreaders.com

Research analysts at Jefferies Financial Group lowered their Q3 2020 EPS estimates for shares of Syneos Health in a research ...

Meeder Asset Management Inc. Boosts Stock Holdings in Syneos Health Inc (NASDAQ:SYNH)

4d ago, source: theenterpriseleader.com

Meeder Asset Management Inc. raised its stake in Syneos Health Inc (NASDAQ:SYNH) by 245.4% during the first quarter, ...

Syneos Health Inc

11d ago, source: Bloomberg

When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

In Vivo CRO Market Trends Estimates High Demand By 2027 - Charles River, Covance, Iris Pharma, MELIOR DISCOVERY and Syneos Health

7d ago, source: Big News Network.com

In Vivo CRO Market Trends Estimates High Demand By 2027 Charles River Covance Iris Pharma MELIOR DISCOVERY and Syneos Health ...

First Week of August 21st Options Trading For Syneos Health (SYNH)

14d ago, source: Nasdaq

Investors in Syneos Health Inc (Symbol: SYNH) saw new options become available this week, for the August 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.